Table 3

Adherence to checklist items by individual journal

Variable	NEJM	Annals IM	The Lancet	The BMJ	JAMA
Title (%)	9*	95	97	100	98
Trial design	30*	70	61	59	39
Eligibility criteria	57	77	83	84	78
Study setting	18*	74	52	85	67
Intervention	78	88	92	88	87
Objective	81	100	99	100	99
Primary outcome	90	86	95	90	90
Random sequence generation	0	21	62†	7	3
Allocation concealment	0	17	22	3	0
Blinding	24*	85	80	73	35*
Number of randomised per group	34*	53	77	66	69
Number of analysed per group	32	33	65	43	41
Outcome stated	85	73	88	74	93
Effect size/precision	77	85	80	81	85
Harms or side effects	69†	38	66	28	43
Interpretation stated	98	100	100	98	100
Trial registration	97	89	99	95	97
Source of funding	98	76	94	3*	2*
Overall adherence	55	70	78	65	63